{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:13:03Z","timestamp":1789056783967,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jacl.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T03:21:48Z","timestamp":1431746508000},"page":"525-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Residual dyslipidemia according to low-density lipoprotein cholesterol, non\u2013high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010"],"prefix":"10.1016","volume":"9","author":[{"given":"Nathan D.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanglu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Rosenblit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.05.003_bib1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2005.07.006","article-title":"The forgotten majority: unfinished business in cardiovascular risk reduction","volume":"46","author":"Libby","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2013.03.041","article-title":"Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010)","volume":"112","author":"Wong","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5830\/CVJA-2013-071","article-title":"Prevalence of dyslipidemia in statin-treated patients in South Africa: results of the DYSlipideaemia International Study (DYSIS)","volume":"24","author":"Raal","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.jacl.2015.05.003_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2014.05.916","article-title":"DYSIS-China Study Investigators. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS)","volume":"235","author":"Zhao","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.05.003_bib5","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/S0828-282X(10)70454-2","article-title":"DYSIS Canadian Investigators. Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS)","volume":"26","author":"Goodman","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacl.2012.04.002","article-title":"Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels","volume":"6","author":"Querton","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.05.003_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/STROKEAHA.113.004229","article-title":"Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients","volume":"45","author":"Sirimarco","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jacl.2015.05.003_bib8","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.05.003_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1370\/afm.214","article-title":"Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000","volume":"3","author":"Koopman","year":"2005","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jacl.2015.05.003_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2015.05.003_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.05.003_bib12","unstructured":"NHANES 2009\u20132010 Laboratory\/Medical Technologists Procedures Manual Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention. 2009."},{"key":"10.1016\/j.jacl.2015.05.003_bib13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2015.05.003_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.05.003_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2008.04.052","volume":"52","author":"Ballantyne","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib16","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","article-title":"On-treatment non-HDL cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: the JUPITER trial","volume":"59","author":"Mora","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ahj.2010.12.014","article-title":"Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participate in Get With the Guidelines (GWTG)","volume":"161","author":"Javed","year":"2011","journal-title":"Am Heart J"},{"issue":"25 Pt B","key":"10.1016\/j.jacl.2015.05.003_bib18","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2015.05.003_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1-executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.05.003_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS Guidelines for the management of dyslipidemia. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.05.003_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","article-title":"2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia- full report","volume":"8","year":"2014","journal-title":"J Clin Lipodol"},{"issue":"suppl 1","key":"10.1016\/j.jacl.2015.05.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists'Guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endo Prac"},{"key":"10.1016\/j.jacl.2015.05.003_bib24","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2008.02.034","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation","volume":"51","author":"Brunzell","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/07853890.2011.582135","article-title":"Clinical response to statins: mechanism(s) of variable activity and adverse effects","volume":"44","author":"Sirtori","year":"2012","journal-title":"Ann Med"},{"issue":"suppl","key":"10.1016\/j.jacl.2015.05.003_bib26","doi-asserted-by":"crossref","first-page":"36K","DOI":"10.1016\/j.amjcard.2005.08.006","article-title":"Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B","volume":"96","author":"Stein","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2015.05.003_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacl.2015.05.003_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study: implications for LDL management","volume":"1","author":"Cromwell","year":"2007","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.05.003_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2015.05.003_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2014.05.914","article-title":"Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets","volume":"235","author":"Toth","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741500238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741500238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T15:20:20Z","timestamp":1537629620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741500238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S193328741500238X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.05.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual dyslipidemia according to low-density lipoprotein cholesterol, non\u2013high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}